| Genetic regulation of the RUNX transcription factor family has antitumor effects K Morita, K Suzuki, S Maeda, A Matsuo, Y Mitsuda, C Tokushige, ... The Journal of clinical investigation 127 (7), 2815-2828, 2017 | 119 | 2017 |
| Cytoprotective autophagy maintains leukemia-initiating cells in murine myeloid leukemia Y Sumitomo, J Koya, K Nakazaki, K Kataoka, T Tsuruta-Kishino, K Morita, ... Blood, The Journal of the American Society of Hematology 128 (12), 1614-1624, 2016 | 91 | 2016 |
| EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified Neuroblastoma AD Durbin, T Wang, VK Wimalasena, MW Zimmerman, D Li, NV Dharia, ... Cancer discovery 12 (3), 730-751, 2022 | 71 | 2022 |
| BAALC potentiates oncogenic ERK pathway through interactions with MEKK1 and KLF4 K Morita, Y Masamoto, K Kataoka, J Koya, Y Kagoya, H Yashiroda, T Sato, ... Leukemia 29 (11), 2248-2256, 2015 | 49 | 2015 |
| RUNX1 positively regulates the ErbB2/HER2 signaling pathway through modulating SOS1 expression in gastric cancer cells Y Mitsuda, K Morita, G Kashiwazaki, J Taniguchi, T Bando, M Obara, ... Scientific reports 8 (1), 6423, 2018 | 36 | 2018 |
| Autonomous feedback loop of RUNX1-p53-CBFB in acute myeloid leukemia cells K Morita, M Noura, C Tokushige, S Maeda, H Kiyose, G Kashiwazaki, ... Scientific reports 7 (1), 16604, 2017 | 36 | 2017 |
| RUNX transcription factors potentially control E-selectin expression in the bone marrow vascular niche in mice K Morita, C Tokushige, S Maeda, H Kiyose, M Noura, A Iwai, M Yamada, ... Blood Advances 2 (5), 509-515, 2018 | 21 | 2018 |
| Paradoxical enhancement of leukemogenesis in acute myeloid leukemia with moderately attenuated RUNX1 expressions K Morita, S Maeda, K Suzuki, H Kiyose, J Taniguchi, PP Liu, H Sugiyama, ... Blood Advances 1 (18), 1440-1451, 2017 | 20 | 2017 |
| Unique association of Waldenström macroglobulinemia with optic neuritis and monoclonal T cell expansion K Morita, A Yoshimi, A Masuda, M Ichikawa, Y Yatomi, M Kurokawa International journal of hematology 98, 247-249, 2013 | 11 | 2013 |
| Primary MALT lymphoma of the urinary bladder in the background of interstitial cystitis K Morita, F Nakamura, Y Nannya, A Nomiya, S Arai, M Ichikawa, ... Annals of hematology 91, 1505-1506, 2012 | 11 | 2012 |
| CD146 is a potential immunotarget for neuroblastoma S Obu, K Umeda, H Ueno, M Sonoda, K Tasaka, H Ogata, K Kouzuki, ... Cancer Science 112 (11), 4617-4626, 2021 | 8 | 2021 |
| Pituitary lymphoma developing within pituitary adenoma K Morita, F Nakamura, Y Kamikubo, N Mizuno, M Miyauchi, G Yamamoto, ... International journal of hematology 95, 721-724, 2012 | 8 | 2012 |
| Pivotal role of DPYSL2A in KLF4-mediated monocytic differentiation of acute myeloid leukemia cells M Noura, K Morita, H Kiyose, H Matsuo, Y Nishinaka-Arai, M Kurokawa, ... Scientific Reports 10 (1), 20245, 2020 | 7 | 2020 |
| RUNX1 transactivates BCR‐ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia T Masuda, S Maeda, S Shimada, N Sakuramoto, K Morita, A Koyama, ... Cancer Science 113 (2), 529-539, 2022 | 5 | 2022 |
| Albendazole induces the terminal differentiation of acute myeloid leukaemia cells to monocytes by stimulating the Krüppel‐like factor 4‐dihydropyrimidinase‐like 2A (KLF4 … M Noura, K Morita, H Kiyose, Y Okuno, H Matsuo, A Koyama, ... British Journal of Haematology 194 (3), 598-603, 2021 | 4 | 2021 |
| Suppression of malignant rhabdoid tumors through Chb‐M′‐mediated RUNX1 inhibition T Daifu, M Mikami, H Hiramatsu, A Iwai, K Umeda, M Noura, H Kubota, ... Pediatric Blood & Cancer 68 (2), e28789, 2021 | 4 | 2021 |
| Physical interaction between BAALC and DBN1 induces chemoresistance in leukemia H Maki, A Yoshimi, T Shimada, S Arai, K Morita, Y Kamikubo, M Ikegawa, ... Experimental Hematology 94, 31-36, 2021 | 3 | 2021 |
| Autoimmune neutropenia preceding Helicobacter pylori-negative MALT lymphoma with nodal dissemination S Harada, S Yamazaki, F Nakamura, K Morita, A Yoshimi, ... International Journal of Clinical and Experimental Pathology 7 (9), 6386, 2014 | 3 | 2014 |
| Simple but powerful prognostic scoring model for MALT lymphoma: a retrospective study K Morita, Y Nannya, T Yoshizato, M Kurokawa Annals of hematology 92, 421-423, 2013 | 2 | 2013 |
| EP300 controls the oncogenic enhancer landscape of high-risk neuroblastoma AD Durbin, V Wimalasena, MW Zimmerman, L Deyao, ES Frank, P Park, ... CANCER RESEARCH 80 (14), 37-37, 2020 | 1 | 2020 |
Hiroshi SugiyamaKyoto UniversityVerified email at kuchem.kyoto-u.ac.jp
